Clinical Trial: Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer
Study Status: Completed
Recruit Status: Completed
Condition: Effect of Drug
Study Type: Interventional
Official Title: Treatment With Nivolumab and All-trans Retinoic Acid for Patients With Refractory Pancreatic Cancer
Brief Summary:
This study is to examine the anticancer activity of the combination therapy with all-trans retinoic acid and nivolumab in patients with chemotherapy-refractory advanced or metastatic pancreatic adenocarcinoma.
Read more